knowledge -WSS

knowledge

author：knowledge 2025-09-09 19:33:02 - browse：92739

A crowd of miniature figurines facing towards an hourglass. -- cancer coverage from STAT — Adobe

It’s no secret that a lucky few seem to glide into old age, the years settling gracefully on their bodies, while others appear to have been dragged through time tied to a metaphorical garbage truck. Biologists have been developing numerous ways to measure the rate an individual ages — often called an accelerated or decelerated “biological age” — and trying to translate it into a heightened or reduced risk of the morbidity and mortality that comes with aging.

There’s been a proliferation of various biological aging clocks, mathematical models that look at things like genetic markers or proteins in your body to make some estimation of an individual’s biological age. Research interest in using these clocks has exploded. In the last five years, thousands of papers on or incorporating the clocks have been published. The paper describing one popular biological aging clock, PhenoAge, has over 1,800 citations alone. One recent study suggested that a reason cancer incidence is increasing among younger adults may be accelerated aging, based on this particular clock.

But as scientists use these clocks to associate biological age with specific health risks, like cancer or dementia, and numerous companies eagerly offer biological age measurements in exchange for hundreds of bucks, it may be worth noting that experts don’t agree on what “biological age” actually is.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

WSS

Congress gives doctors Medicare pay bump

FogPharma raises $145 million in rare Series E round

A new nitrogen execution bill also undermines medical licensing

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

RSV vaccines may be linked to small increased risk of developing GBS

Antivenom research: Lessons from HIV applied in search for universal antidote

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Walensky prepares to leave CDC — and Congress — behind

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

BioMarin wins approval for gene therapy to treat hemophilia A

New documents shed light on MD Anderson Cancer Institute feud

Wildfire smoke exposes gaps in outdoor worker protections

How to fix the rural physician shortage in the U.S.

New air purifier tech could be key to improving indoor air quality

An inside look at PIPEs, biotech's buzzy new financing tool

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

RaDonda Vaught to speak at CommonSpirit event on patient safety

focus

R1 RCM gets $5.8 billion buyout offer from private equity firm

Covid isolation guidance eased by the CDC

How to fix the rural physician shortage in the U.S.

FDA does about

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

AstraZeneca loses challenge to Medicare drug price negotiation

focus

focus

focus

focus